Table 1 Correlation between Klotho expression and clinical characteristics of DLBCL patients
Characteristics | No. of patients | Klotho expression | p value | |
|---|---|---|---|---|
Positive (%) | Negative | |||
Age (years) | ||||
 <60 | 27 | 4(14.8%) | 23 | 0.857 |
 ≥60 | 23 | 3(13.0%) | 20 | |
Gender | ||||
 Male | 26 | 2(7.7%) | 24 | 0.181 |
 Female | 24 | 5(20.8%) | 19 | |
Ann Arbor stage | ||||
 I or II | 12 | 5(41.7%) | 7 | 0.002 |
 III or IV | 38 | 2(5.3%) | 36 | |
B symptoms | ||||
 Present | 14 | 2(14.3%) | 12 | 0.971 |
 Absent | 36 | 5(13.9%) | 31 | |
Subtype | ||||
 GCB | 15 | 2(13.3%) | 13 | 0.929 |
 Non-GCB | 35 | 5(14.3%) | 30 | |
Serum LDH | ||||
 Normal | 35 | 5(14.3%) | 30 | 0.929 |
 Elevated | 15 | 2(13.3%) | 13 | |
Extranodal involvement | ||||
 Absent | 28 | 4(14.3%) | 18 | 0.45 |
 Present | 22 | 3(13.7%) | 25 | |
IPI score | ||||
 0–2 | 35 | 6(17.1%) | 29 | 0.328 |
 3–5 | 15 | 1(6.7%) | 14 | |